- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT05457283
Uno studio per saperne di più sulla sicurezza del trattamento in studio Il finerenone è in uso a lungo termine se assunto con un ACE inibitore o un bloccante del recettore dell'angiotensina oltre 18 mesi di utilizzo in bambini e giovani adulti da 1 a 18 anni di età con malattia renale cronica e Proteinuria (FIONA OLE)
Uno studio di estensione della sicurezza a braccio singolo, in aperto, della durata di 18 mesi, di un regime di finerenone orale aggiustato per età e peso corporeo, in aggiunta a un ACEI o ARB, per il trattamento di bambini e giovani adulti da 1 a 18 anni di età Con malattia renale cronica e proteinuria
Researchers are looking for a better way to treat children who have chronic kidney disease (CKD), which is long-term kidney disease, and proteinuria, a condition in which a person´s kidneys leak protein into the urine.
The kidneys filter waste and fluid from the blood to form urine. In children with CKD, the kidney´s filters do not work as well as they should. This can lead to accumulation of waste and fluid in the body and proteinuria. CKD can lead to other medical problems, such as high blood pressure, also known as hypertension. Vice versa, hypertension and proteinuria can also contribute to worsening of CKD. Therefore, the treatment of CKD aims to control blood pressure and proteinuria. There are treatments available for doctors to prescribe to children with CKD and hypertension and/or proteinuria. These include "angiotensin-converting enzyme inhibitors" (ACEI) and "angiotensin receptor blockers" (ARB). Both ACEI and ARB can help improve kidney function by reducing the activity of the renin-angiotensin-aldosterone system (RAAS). The RAAS is a system that works with the kidneys to control blood pressure and the balance of fluid and electrolytes in the blood. In people with CKD, the RAAS is often too active, which can impair the ability of the kidneys to work properly and cause hypertension and proteinuria. However, ACEI or ARB treatment alone does not work for all patients with CKD as they only target the angiotensin part of the renin-angiotensin-aldosterone system.
The study treatment, finerenone, is expected to help control RAAS overactivation together with an ACEI or ARB.
So, the researchers in this study want to learn more about whether finerenone given in addition to either an ACEI or ARB can help their kidney function.
The main purpose of this study is to learn how safe the treatment is when used of finerenone in addition to an ACEI or ARB in long-term.
To see how safe the treatment is, the study team will collect information on medical problems which are also known as "treatment emergent adverse events" (TEAEs). And they will also collect levels of an electrolyte called potassium in the blood by taking blood samples, and measure blood pressure during the study.
The secondary purpose of this study is to learn how well long-term use of finerenone can reduce the amount of protein in the participants' urine and benefit kidney function when taken with standard of care.
To see how the treatment works, the study team will collect participants' urine samples to assess urinary albumin-to-creatinine ratio (UACR) and urinary protein-to-creatinine ratio (UPCR), which are important assessments for calculating the level of protein in the urine. Researchers will also collect blood samples to analyze serum creatinine and calculate estimated glomerular filtration rate (eGFR). A significant decline in eGFR indicates worsening kidney function.
The study will include participants who had previously participated in FIONA study (NCT05196035). The participants will be aged from 1 year up to 18 years.
The participants will be in the study for approximately 19 months. They will take study treatment for up to 18 months and will be follow up for 1 month. During this period, at least 12 visits are planned for patients who newly start finerenone, and at least 8 visits for patients who already received finerenone.
In the visit, the study team will:
- have their blood pressure, heart rate, temperature, height and weight measured
- have blood and urine samples taken
- have physical examinations
- have their heart examined by an electrocardiogram and echocardiography (a sonogram of the heart)
- answer questions about their medication and whether they have any adverse events, or have their parents or guardian's answer
- answer questions about how they are feeling, or have their parents or guardian's answer
- answer question about how they like the study medication, or have their parents or guardian's answer The doctors will keep track of any adverse events. An adverse event is any medical problem that a participant has during a study. Doctors keep track of all adverse events that happen in studies, even if they do not think the adverse events might be related to the study treatments.
The doctors will check the participants' health about 30 days after the participants take their last treatment.
Panoramica dello studio
Stato
Condizioni
Intervento / Trattamento
Tipo di studio
Iscrizione (Stimato)
Fase
- Fase 3
Contatti e Sedi
Contatto studio
- Nome: Bayer Clinical Trials Contact
- Numero di telefono: 18888422937
- Email: clinical-trials-contact@bayer.com
Luoghi di studio
-
-
-
Buenos Aires, Argentina, C1199ABB
- Attivo, non reclutante
- Hospital Italiano de Buenos Aires
-
Buenos Aires, Argentina, C1249ABN
- Ritirato
- Hospital de Pediatría Juan P. Garrahan
-
Buenos Aires, Argentina, C1425EFD
- Reclutamento
- Hospital General de Ninos Ricardo Gutierrez | Pediatric Nephrology Department
-
Buenos Aires, Argentina, C1270AAN
- Attivo, non reclutante
- Hospital General de Ninos Pedro de Elizalde | Nephrology Department
-
San Luis, Argentina, D5700CGR
- Attivo, non reclutante
- Centro de Rehabilitacion Cardiovascular | San Luis, Argentina
-
-
Santa Fe Province
-
Santa Fe, Santa Fe Province, Argentina, S3000
- Ritirato
- Clinica de Nefrologia, Urologia y Enfermedades Cardiovascualares | Santa Fe, Argentina
-
-
-
-
Queensland
-
South Brisbane, Queensland, Australia, 4101
- Attivo, non reclutante
- Queensland Children's Hospital
-
-
Victoria
-
Clayton, Victoria, Australia, 3168
- Ritirato
- Monash Children's Hospital
-
Parkville, Victoria, Australia, 3052
- Reclutamento
- Royal Children's Hospital Melbourne
-
-
-
-
State of Vienna
-
Vienna, State of Vienna, Austria, 1090
- Ritirato
- Uniklinikum Salzburg - Landeskrankenhaus
-
Vienna, State of Vienna, Austria, 1090
- Ritirato
- Universitätsklinikum AKH Wien
-
-
Styria
-
Graz, Styria, Austria, 8036
- Ritirato
- Medizinische Universität Graz, Landeskrankenhaus-Universitätsklinikum Graz
-
-
Tyrol
-
Innsbruck, Tyrol, Austria, 6020
- Completato
- Kepler Universitätsklinikum Campus IV
-
-
-
-
-
Liège, Belgio, 4000
- Ritirato
- CHC Montlégia - Pediatrics
-
-
Brussels Capital
-
Brussels, Brussels Capital, Belgio, 1020
- Ritirato
- Huderf / Ukzkf
-
Brussels, Brussels Capital, Belgio, 1200
- Ritirato
- CU Saint-Luc/UZ St-Luc
-
-
East Flanders
-
Ghent, East Flanders, Belgio, 9000
- Attivo, non reclutante
- UZ Gent
-
-
Flemish Brabant
-
Leuven, Flemish Brabant, Belgio, 3000
- Completato
- UZ Gasthuisberg - Pediatric Nephrology
-
-
-
-
-
São Paulo, Brasile, 05403 000
- Non ancora reclutamento
- Instituto da Crianca e do Adolescente
-
São Paulo, Brasile, 13034-685
- Reclutamento
- Hospital PUC-Campinas | Centro de Pesquisa Clínica Sao Lucas
-
São Paulo, Brasile, 01227-200
- Ritirato
- Hospital Infantil Sabará - Instituto PENSI - Pesquisa e Ensino em Saúde Infantil
-
São Paulo, Brasile, 30150-221
- Reclutamento
- Santa Casa de Misericórdia de Belo Horizonte
-
-
Paraná
-
Curitiba, Paraná, Brasile, 80250-060
- Reclutamento
- Hospital Pequeno Principe
-
-
São Paulo
-
Ribeirão Preto, São Paulo, Brasile, 14051-140
- Attivo, non reclutante
- Hosp Clínicas Facult. Med. de Ribeirão Preto / USP
-
-
-
-
Plovdiv Province
-
Plovdiv, Plovdiv Province, Bulgaria, 4002
- Reclutamento
- UMHAT Sveti Georgi
-
-
Sofia City Province
-
Sofia, Sofia City Province, Bulgaria, 1606
- Ritirato
- SHATPD "Prof. Ivan Mitev"
-
-
Stara Zagora Province
-
Stara Zagora, Stara Zagora Province, Bulgaria, 6003
- Ritirato
- MHAT prof. Stoyan Kirkovitch AD
-
-
-
-
Alberta
-
Calgary, Alberta, Canada, T3B 6A8
- Ritirato
- Alberta Children's Hospital | Nephrology Clinic
-
-
Quebec
-
Montreal, Quebec, Canada, H3T 1C5
- Completato
- Centre hospitalier universitaire Sainte-Justine | Cardiology
-
-
-
-
Prague
-
Prague, Prague, Cechia, 150 06
- Attivo, non reclutante
- Fakultní nemocnice Motol a Homolka, Pracoviště MOTOL
-
Prague, Prague, Cechia, 128 08
- Completato
- Všeobecná fakultní nemocnice v Praze
-
-
-
-
-
Daegu, Corea del Sud, 41944
- Completato
- Kyungpook National University Hospital | Pediatric Nephrology
-
Seoul, Corea del Sud, 03080
- Attivo, non reclutante
- Seoul National University Hospital | Pediatric Nephrology
-
Seoul, Corea del Sud, 08308
- Ritirato
- Korea University Guro Hospital | Pediatric Nephrology
-
-
Gyeonggi-do
-
Seongnam-si, Gyeonggi-do, Corea del Sud, 13620
- Completato
- Seoul National University Bundang Hospital | Pediatric Nephrology
-
-
Gyeongsangnam-do
-
Yangsan, Gyeongsangnam-do, Corea del Sud, 50612
- Attivo, non reclutante
- Pusan National University Children's Hospital | Pediatric Nephrology
-
-
-
-
Capital Region / Region Hovedstaden
-
Copenhagen, Capital Region / Region Hovedstaden, Danimarca, 2100
- Ritirato
- Rigshospitalet - Børn og Unge
-
-
Central Denmark Region / Region Midtjylland
-
Aarhus N, Central Denmark Region / Region Midtjylland, Danimarca, 8200
- Completato
- Aarhus Universitetshospital - Børn og Unge
-
-
Region of Southern Denmark / Region Syddanmark
-
Odense, Region of Southern Denmark / Region Syddanmark, Danimarca, 5000
- Attivo, non reclutante
- Odense Universitetshospital - HC Andersen Børne og Ungehospital
-
-
-
-
Pirkanmaa
-
Tampere, Pirkanmaa, Finlandia, 33521
- Reclutamento
- Tampere University Hospital, Tampereen yliopistollinen sairaala (TAYS) - Lasten lääketutkimuskeskus PeeTU
-
-
Southwest Finland
-
Turku, Southwest Finland, Finlandia, 20520
- Ritirato
- Turun yliopistollinen keskussairaala
-
-
Uusimaa
-
Helsinki, Uusimaa, Finlandia, 00290
- Reclutamento
- HUS-Yhtymä, Helsingin yliopistollinen sairaala (HUS) - Uusi lastensairaala, nefrologia
-
-
-
-
-
Bron, Francia, 69500
- Completato
- CHU Lyon - Hopital Femme Mere Enfant - Service de nephrologie-rhumatologie-dermatologie pediatriques
-
Montpellier, Francia, 34295
- Attivo, non reclutante
- CHU Montpellier - Hopital Arnaud de Villeneuve - Service nephrologie pediatrique
-
Strasbourg, Francia, 67200
- Ritirato
- CHU Strasbourg - Hopital Hautepierre - Service nephrologie pediatrique
-
-
New Aquitaine
-
Bordeaux, New Aquitaine, Francia, 33076
- Ritirato
- CHU bordeaux - Hopital Pellegrin
-
-
Occitanie
-
Toulouse, Occitanie, Francia, 31059
- Completato
- CHU Toulouse - Hopital des enfants
-
-
Île-de-France Region
-
Paris, Île-de-France Region, Francia, 75019
- Attivo, non reclutante
- APHP - Hopital Robert Debre
-
-
-
-
-
Berlin, Germania, 13353
- Attivo, non reclutante
- Charité / Pädiatrie
-
Hamburg, Germania, 20246
- Ritirato
- Universitätsklinikum Hamburg Eppendorf (UKE)
-
-
Baden-Wurttemberg
-
Heidelberg, Baden-Wurttemberg, Germania, 69115
- Ritirato
- Universitätsklinikum Heidelberg
-
-
Lower Saxony
-
Hanover, Lower Saxony, Germania, 30625
- Ritirato
- Medizinische Hochschule Hannover (MHH) | Zentrum Innere Medizin | Klinik fuer Kardiologie und Angiologie
-
-
North Rhine-Westphalia
-
Bonn, North Rhine-Westphalia, Germania, 53127
- Attivo, non reclutante
- Kindernierenzentrum Bonn
-
Essen, North Rhine-Westphalia, Germania, 45147
- Attivo, non reclutante
- Universitätsklinikum Essen
-
Münster, North Rhine-Westphalia, Germania, 48149
- Ritirato
- Universitätsklinikum Münster
-
-
-
-
-
Athens, Grecia, 11527
- Reclutamento
- Children's Hospital of Athens Agia Sofia - Pediatric Nephrology Department
-
Athens, Grecia, 11526
- Reclutamento
- Children's Hospital of Athens P&A Kyriakou - Pediatric Nephrology Department
-
Heraklion, Grecia, 71110
- Attivo, non reclutante
- University General Hospital of Heraklion
-
Ioannina, Grecia, 45500
- Attivo, non reclutante
- University General Hospital Of Ioannina-Child Health Sector
-
Thessaloniki, Grecia, 54642
- Ritirato
- Ippokratio General Hospital Of Thessaloniki-Pediatric Nephrology Unit, 3rd Department of Paediatrics
-
-
-
-
Gujarat
-
Ahmedabad, Gujarat, India, 380052
- Attivo, non reclutante
- Mavani Kidney Care
-
-
Karnataka
-
Bengaluru, Karnataka, India, 560034
- Attivo, non reclutante
- St. John's National Academy of Health Sciences
-
-
National Capital Territory of Delhi
-
Delhi, National Capital Territory of Delhi, India, 110029
- Attivo, non reclutante
- All India Institute of Medical Sciences (AIIMS) - New Delhi
-
-
West Bengal
-
Kolkata, West Bengal, India, 700014
- Attivo, non reclutante
- NRS Medical college
-
-
-
-
-
Beersheba, Israele, 8410101
- Attivo, non reclutante
- Clalit Health | Soroka Medical Center
-
Jerusalem, Israele, 9103102
- Attivo, non reclutante
- Wilf Children's Hospital Shaare Zedek Medical Center
-
Nahariya, Israele, 2210001
- Completato
- Health Corporation of Galilee Medical Center
-
Petah Tikva, Israele, 4920235
- Completato
- Clalit Health Services Schneider Children's Medical Center
-
Tel Aviv, Israele, 6423906
- Attivo, non reclutante
- Dana-Dwek Children's Hospital
-
-
-
-
-
Bologna, Italia, 40138
- Completato
- Azienda Ospedaliero-Universitaria Di Bologna IRCCS_Policlinico Sant'Orsola - Pediatria
-
Florence, Italia, 50139
- Reclutamento
- Azienda Ospedaliera Universitaria Meyer IRCCS - Nefrologia e Dialisi
-
Genova, Italia, 16147
- Completato
- IRCCS Istituto Giannina Gaslini - Nefrologia e Trapianto Rene
-
Milan, Italia, 20122
- Completato
- Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico - Nefrologia e Dialisi Pediatrica, Trapianti di Rene
-
Roma, Italia, 00165
- Completato
- Ospedale Pediatrico Bambino Gesù - Nefrologia
-
Torino, Italia, 10126
- Reclutamento
- A.O.U. Città della Salute e della Scienza di Torino_Regina Margherita - Nefrologia Pediatrica
-
-
-
-
Kaunas County
-
Kaunas, Kaunas County, Lituania, LT-50161
- Attivo, non reclutante
- Hospital of LT University of Health Sciences Kaunas Clinics
-
-
Vilnius County
-
Vilnius, Vilnius County, Lituania, LT-08406
- Attivo, non reclutante
- Vilnius University Hospital Santaros Klinikos Children's Hospital Paediatrics Centre
-
-
-
-
Kelantan
-
Kelantan, Kelantan, Malaysia, 16150
- Reclutamento
- Hospital Universiti Sains Malaysia
-
-
Kuala Lumpur
-
Wilayah Persekutuan Putrajaya, Kuala Lumpur, Malaysia, 50300
- Reclutamento
- Hospital Tunku Azizah
-
-
Negeri Sembilan
-
Seremban, Negeri Sembilan, Malaysia, 70300
- Reclutamento
- Hospital Tuanku Ja'afar
-
-
Selangor
-
Shah Alam, Selangor, Malaysia, 68100
- Reclutamento
- Hospital Selayang
-
Subang Jaya, Selangor, Malaysia, 47500
- Reclutamento
- Sunway Medical Centre
-
-
-
-
-
Veracruz, Messico, 91900
- Ritirato
- Instituto Veracruzano en Investigación Clinica SC
-
-
Agguascalientes
-
Aguascalientes, Agguascalientes, Messico, 20124
- Reclutamento
- Sitio Alfredo Chew Wong | Aguascalientes, Mexico
-
-
Mexico City
-
México D.F., Mexico City, Messico, 6720
- Ritirato
- Hospital Infantil de México "Dr. Federico Gómez"
-
México, D.F., Mexico City, Messico, 4530
- Non ancora reclutamento
- Instituto Nacional de Pediatría
-
-
Nuevo León
-
Monterrey, Nuevo León, Messico, 64460
- Ritirato
- Hospital Universitario "José Eleuterio González"
-
-
-
-
-
Groningen, Olanda, 9713 GZ
- Attivo, non reclutante
- Universitair Medisch Centrum Groningen
-
Utrecht, Olanda, 3584 CX
- Attivo, non reclutante
- University Medical Center Utrecht
-
-
-
-
-
Bialystok, Polonia, 15-274
- Completato
- Uniwersytecki Dzieciecy Szpital Kliniczny im. L. Zamenhofa
-
Gdansk, Polonia, 80-952
- Attivo, non reclutante
- Uniwersyteckie Centrum Kliniczne
-
Krakow, Polonia, 30-663
- Ritirato
- Uniwersytecki Szpital Dzieciecy w Krakowie
-
Lodz, Polonia, 93-338
- Completato
- Instytut Centrum Zdrowia Matki Polki
-
Warsaw, Polonia, 04-730
- Attivo, non reclutante
- Instytut "Pomnik - Centrum Zdrowia Dziecka"
-
Wroclaw, Polonia, 50-556
- Ritirato
- Uniwersytecki Szpital Kliniczny Im. Jana Mikulicza-Radeckiego We Wroclawiu
-
-
-
-
-
Braga, Portogallo, 4710-243
- Ritirato
- Unidade Local de Saúde de Braga E.P.E. - Centro Clínico Académico de Braga - Serviço de Pediatria
-
Coimbra, Portogallo, 3000
- Completato
- Unidade Local de Saúde de Coimbra, E.P.E. - Hospital Pediátrico - Serviço de Pediatria Ambulatória - Nefrologia
-
Porto, Portogallo, 4050-651
- Completato
- Unidade Local de Saúde de Santo António, E.P.E
-
-
-
-
Greater London
-
London, Greater London, Regno Unito, WC1N 3JH
- Attivo, non reclutante
- Great Ormond Street Hospital for Children | Clinical Research Facility
-
-
Greater Manchester
-
Manchester, Greater Manchester, Regno Unito, M13 9WL
- Reclutamento
- Royal Manchester Children's Hospital | Clinical Research Facility
-
-
Nottinghamshire
-
Nottingham, Nottinghamshire, Regno Unito, NG7 2UH
- Ritirato
- Nottingham Children's Hospital | Renal and Urology Unit
-
-
Scotland
-
Glasgow, Scotland, Regno Unito, G51 4TF
- Reclutamento
- Royal Hospital for Children | Glasgow Clinical Research Facility
-
-
-
-
-
Barcelona, Spagna, 08035
- Attivo, non reclutante
- Hospital Universitari Vall D Hebron | Nefrologia pediatrica
-
Madrid, Spagna, 28041
- Completato
- Hospital Universitario 12 De Octubre | Nefrologia pediatrica
-
Madrid, Spagna, 28046
- Attivo, non reclutante
- Hospital Universitario La Paz | Nefrologia pediatrica
-
Málaga, Spagna, 29010
- Reclutamento
- Hospital Universitario Regional De Malaga | Nefrologia pediatrica
-
Seville, Spagna, 41013
- Completato
- Hospital Universitario Virgen Del Rocio S.L. | Nefrologia pediatrica
-
-
Barcelona
-
Esplugues de Llobregat, Barcelona, Spagna, 8950
- Completato
- Hospital Sant Joan De Deu Barcelona | Nefrologia pediatrica
-
-
-
-
Arizona
-
Phoenix, Arizona, Stati Uniti, 85016
- Ritirato
- Phoenix Children's Hospital | Main - Transplant Department
-
-
California
-
Los Angeles, California, Stati Uniti, 90048
- Ritirato
- Cedars-Sinai Samuel Oschin Cancer Center
-
Palo Alto, California, Stati Uniti, 94304
- Attivo, non reclutante
- Lucille Packard Children's Hospital Stanford - Pediatric Nephrology
-
San Diego, California, Stati Uniti, 92123
- Ritirato
- Rady Children's Hospital San Diego - Cardiology
-
-
District of Columbia
-
Washington D.C., District of Columbia, Stati Uniti, 20010
- Ritirato
- Children's National Hospital - Nephrology
-
-
Florida
-
Hollywood, Florida, Stati Uniti, 33021
- Ritirato
- Memorial Transplant Institute - Pediatric Nephrology
-
-
Georgia
-
Atlanta, Georgia, Stati Uniti, 30322
- Ritirato
- Emory University Hospital/Children's Healthcare of Atlanta - Nephrology
-
-
Iowa
-
Iowa City, Iowa, Stati Uniti, 52242
- Ritirato
- University of Iowa Health Care Medical Center - Nephrology
-
-
Maryland
-
Baltimore, Maryland, Stati Uniti, 21287
- Attivo, non reclutante
- The Charlotte R. Bloomberg Children's Center Building - Nephrology
-
-
Massachusetts
-
Boston, Massachusetts, Stati Uniti, 02115
- Ritirato
- Boston Children's Hospital - Main Campus - Nephrology
-
-
Missouri
-
Kansas City, Missouri, Stati Uniti, 64108
- Ritirato
- Children's Mercy Hospital Kansas City - Nephrology
-
-
Ohio
-
Cincinnati, Ohio, Stati Uniti, 45229
- Ritirato
- Cincinnati Children's Hospital Medical Center | Division of Nephrology and Hypertension
-
Cleveland, Ohio, Stati Uniti, 14013
- Completato
- Cleveland Clinic | Pediatric Nephrology
-
-
Oregon
-
Portland, Oregon, Stati Uniti, 97239
- Ritirato
- OHSU Doernbecher Children's Hospital - Neurology
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, Stati Uniti, 19104
- Ritirato
- Children's Hospital of Philadelphia - Nephrology
-
-
Texas
-
San Antonio, Texas, Stati Uniti, 78207
- Ritirato
- University Hospital - San Antonio - Pediatric Nephrology
-
-
Utah
-
Salt Lake City, Utah, Stati Uniti, 84113
- Attivo, non reclutante
- Eccles Primary Children's Outpatient Services - Nephrology
-
-
Washington
-
Seattle, Washington, Stati Uniti, 98105
- Ritirato
- Seattle Children's Hospital - Nephrology
-
-
-
-
Gauteng
-
Soweto, Gauteng, Sud Africa, 1862
- Reclutamento
- Wits Vaccines & Infectious Diseases Analytics (VIDA) Research Unit
-
-
-
-
-
Stockholm - Huddinge, Svezia, 141 86
- Ritirato
- Karolinska Universitetssjukhuset - Huddinge - Barnnjurmedicin
-
-
Skåne County
-
Lund, Skåne County, Svezia, 221 85
- Attivo, non reclutante
- Skånes Universitetssjukhus - Lund - Barnnefroenheten
-
-
Uppsala County
-
Uppsala, Uppsala County, Svezia, 751 85
- Ritirato
- OBSOLETE_Uppsala University Hospital
-
-
-
-
-
Geneva, Svizzera, 1211
- Completato
- Hopital des Enfants HUG
-
-
Canton of Basel-City
-
Basel, Canton of Basel-City, Svizzera, 4031
- Attivo, non reclutante
- Universitäts-Kinderspital UKBB
-
-
Canton of Vaud
-
Lausanne, Canton of Vaud, Svizzera, 1012
- Attivo, non reclutante
- Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne University Hospital
-
-
-
-
-
Kaohsiung City, Taiwan, 813414
- Ritirato
- Kaohsiung Veterans General Hospital
-
Tainan, Taiwan, 704
- Ritirato
- National Cheng Kung University Hospital
-
Taipei, Taiwan, 11217
- Attivo, non reclutante
- Taipei Veterans General Hospital
-
Taipei, Taiwan, 10507
- Reclutamento
- Chang Gung Memorial Hospital at Linkou
-
Taipei, Taiwan, 100229
- Ritirato
- National Taiwan University Hospital
-
-
Taoyuan
-
Guishan, Taoyuan, Taiwan, 83301
- Non ancora reclutamento
- Chang Gung Memorial Hospital (CGMH) - Kaohsiung Branch
-
-
-
-
-
Adana, Turchia (Türkiye), 01790
- Ritirato
- Cukurova Univ. Tip. Fak. Balcali Hastanesi
-
Ankara, Turchia (Türkiye), 6490
- Completato
- Baskent Universitesi Tip Fakultesi Hastanesi
-
Ankara, Turchia (Türkiye), 6560
- Attivo, non reclutante
- Gazi Universitesi Tip Fakultesi
-
Ankara, Turchia (Türkiye), 06230
- Ritirato
- Hacettepe Universitesi Tip Fakultesi
-
Ankara, Turchia (Türkiye), 6800
- Attivo, non reclutante
- T.C. Saglik Bakanligi Ankara Bilkent Sehir Hastanesi Noroloji ve Ortopedi Hastanesi Noroloji Bolumu
-
Istanbul, Turchia (Türkiye), 34899
- Completato
- Marmara University Medical Faculty | Pediatric Nephrology
-
Istanbul, Turchia (Türkiye), 34093
- Attivo, non reclutante
- Istanbul Faculty of Medicine, Department of Internal Medicine, Department of Pediatrics
-
Istanbul, Turchia (Türkiye), 34098
- Completato
- Istanbul Universitesi Cerrahpasa - Cocuk Nefrolojisi
-
-
-
-
-
Budapest, Ungheria, 1083
- Attivo, non reclutante
- Semmelweis University
-
-
Baranya
-
Pécs, Baranya, Ungheria, 7623
- Completato
- Pecsi Tudomanyegyetem Klinikai Kozpont
-
-
Csongrád-Csanád
-
Szeged, Csongrád-Csanád, Ungheria, 6720
- Ritirato
- Szegedi Tudományegyetem Szent-Györgyi Albert Klinikai Központ
-
-
Hajdú-Bihar
-
Debrecen, Hajdú-Bihar, Ungheria, 4032
- Completato
- Debreceni Egyetem Klinikai Kozpont
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
Inclusion Criteria:
-
Participants must be ≥1 year to 18 years of age, at the time of signing the informed consent/assent.
-
Prior participation in the finerenone Phase 3 study FIONA (19920) and not permanently discontinued from treatment by the end of treatment (EoT) visit in FIONA.
-
Participants must have a clinical diagnosis of chronic kidney disease (CKD) at Visit 1 which is defined as
- CKD stages 1-3 (estimated glomerular filtration rate [eGFR] ≥30 mL/min/1.73m^2) for children ≥1 year to <19 years of age at FIONA EoT and at Visit 1
-
Treated with an angiotensin-converting enzyme inhibitor (ACEI) or angiotensin receptor blocker (ARB) at optimized doses defined as maximally tolerable doses within the recommended dose range according to guidelines on blood pressure (BP) management, unchanged for at least 30 days prior to Visit 1.
-
K+ ≤5.0 mmol/L for children ≥2 years of age at both FIONA EoT and Visit 1, and ≤5.3 mmol/L for children <2 years of age at both FIONA EoT and Visit 1
-
Participants who have reached legal age of consent: Capable of giving signed informed consent.
-
Participant is able to receive enteral feeding (solid food, bottle or cup fed, feeding through nasogastric or gastric feeding tubes) with or without breastfeeding.
Exclusion Criteria:
- Planned urological surgery expected to influence renal function
- Patients who are candidates for renal transplantation, i.e., a kidney transplantation scheduled within the study time frame
- Systemic hypertension Stage 2 defined according to institutional guidelines on BP management at Visit 1.
- Systemic hypotension defined as symptomatic hypotension or a mean systolic BP below the 5th percentile for age, sex and height but no lower than 80 mmHg for participants <18 years and symptomatic hypotension or a mean systolic blood pressure (SBP) <90 mmHg in participants ≥18 years at Visit 1.
- Known hypersensitivity to the study treatment (active substance or excipients)
- Severe hepatic insufficiency defined by e.g. Child-Pugh C or analogous scores.
- Participants using rituximab, cyclophosphamide, abatacept, or intravenous glucocorticoids
- Concomitant therapy with a mineralocorticoid receptor antagonist (MRA)(eplerenone, spironolactone, esaxerenone, canrenone), any renin inhibitor (aliskiren, enalkiren, remikiren), any sodium-glucose co-transporter-2 (SGLT2) inhibitor (SGLT2i), sacubitril/valsartan combination (ARNI), or potassium-sparing diuretic (amiloride, triamterene)
- Concomitant therapy with both ACEI and ARBs together
- Concomitant therapy with strong cytochrome P450 isoenzyme 3A4 (CYP3A4) inhibitors, moderate or strong CYP3A4 inducers
- Previous assignment to treatment during this study
- Simultaneous participation in another interventional clinical study (e.g., Phase 1 to 4 clinical studies).
- Any suspected (serious) adverse event related to study intervention which led to permanent discontinuation during the FIONA study.
- Pregnant or breastfeeding or intention to become pregnant during the study
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Trattamento
- Assegnazione: N / A
- Modello interventistico: Assegnazione di gruppo singolo
- Mascheramento: Nessuno (etichetta aperta)
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
|---|---|
|
Sperimentale: Finerenone Open-Label safety Extension
Participants will receive finerenone treatment. |
Finerenone in different doses, treatment duration will be 540 ±7 days. |
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Lasso di tempo |
|---|---|
|
Numero di partecipanti con evento avverso emergente dal trattamento (TEAE)
Lasso di tempo: Fino a 550 giorni
|
Fino a 550 giorni
|
|
Variazione dei livelli sierici di potassio dal basale al giorno 540±7
Lasso di tempo: Fino a 547 giorni
|
Fino a 547 giorni
|
|
Variazione della pressione arteriosa sistolica (SBP) dal basale al giorno 540±7
Lasso di tempo: Fino a 547 giorni
|
Fino a 547 giorni
|
Misure di risultato secondarie
Misura del risultato |
Lasso di tempo |
|---|---|
|
Modifica del rapporto proteine urinarie/creatinina (UPCR) dal basale al giorno 540 ± 7
Lasso di tempo: Fino a 547 giorni
|
Fino a 547 giorni
|
|
Variazione del rapporto albumina/creatinina urinaria (UACR) dal basale al giorno 540±7
Lasso di tempo: Fino a 547 giorni
|
Fino a 547 giorni
|
|
Variazione della velocità di filtrazione glomerulare stimata (eGFR) dal basale al giorno 540±7
Lasso di tempo: Fino a 547 giorni
|
Fino a 547 giorni
|
Collaboratori e investigatori
Sponsor
Studiare le date dei record
Studia le date principali
Inizio studio (Effettivo)
Completamento primario (Stimato)
Completamento dello studio (Stimato)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Termini MeSH pertinenti aggiuntivi
- Malattie urogenitali
- Processi patologici
- Malattie urogenitali maschili
- Malattie renali
- Malattie urologiche
- Malattie urogenitali femminili
- Malattie urogenitali femminili e complicanze della gravidanza
- Malattia cronica
- Attributi della malattia
- Disturbi della minzione
- Manifestazioni urologiche
- Insufficienza renale
- Condizioni patologiche, segni e sintomi
- Segni e sintomi
- Insufficienza renale cronica
- Proteinuria
- finenone
Altri numeri di identificazione dello studio
- 20186
- 2021-002905-89 (Numero EudraCT)
- 2023-504885-50-00 (Identificatore di registro: CTIS (EU))
- 2023 (Sovvenzione/contratto NIH degli Stati Uniti)
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Descrizione del piano IPD
Availability of this study's data will later be determined according to Bayer's commitment to the EFPIA/PhRMA "Principles for responsible clinical trial data sharing". This pertains to scope, timepoint and process of data access. As such, Bayer commits to sharing upon request from qualified researchers patient-level clinical trial data, study-level clinical trial data, and protocols from clinical trials in patients for medicines and indications approved in the US and EU as necessary for conducting legitimate research. This applies to data on new medicines and indications that have been approved by the EU and US regulatory agencies on or after January 01, 2014. Interested researchers can use www.vivli.org to request access to anonymized patient-level data and supporting documents from clinical studies to conduct research. Information on the Bayer criteria for listing studies and other relevant information is provided in the member section of the portal.
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .